1 – 10 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Oral administration of live exopolysaccharide-producing Pediococcus parvulus, but not purified exopolysaccharide suppressed Enterobacteriaceae without affecting bacterial diversity in caecum of mice.
(
- Contribution to journal › Article
- 2012
-
Mark
Evaluation of commercial microbial hydrocolloids concerning their effects on plasma lipids and caecal formation of SCFA in mice
(
- Contribution to journal › Article
-
Mark
Effects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice
(
- Contribution to journal › Article
- 2010
-
Mark
Characterization of the properties of Pediococcus parvulus for probiotic or protective culture use.
(
- Contribution to journal › Article
- 2007
-
Mark
Nutritional properties of oat-based beverages as affected by processing and storage
(
- Contribution to journal › Article
- 2005
-
Mark
Fermented, ropy, oat-based products reduce cholesterol levels and stimulate the bifidobacteria flora in humans
(
- Contribution to journal › Article
-
Mark
Growth and exopolysaccharide formation by Pediococcus damnosus 2.6 in beta-glucan suspensions of oat and barley
(
- Contribution to journal › Article
- 2003
-
Mark
Development of an oat-based sour milk-like product
(
- Contribution to journal › Article
-
Mark
Comparison of growth characteristics and exopolysaccharide formation of two lactic acid bacteria strains, Pediococcus damnosus 2.6 and Lactobacillus brevis G-77, in an oat-based, non-dairy medium.
(
- Contribution to journal › Article
- 2002
-
Mark
Effects of fermented, ropy, non-dairy, oat-based products on serum lipids and the faecal excretion of cholesterol and short chain fatty acids in germfree and conventional rats
(
- Contribution to journal › Article